glp 1 examples brand name How GLP-1 medications are transforming diabetes and weight loss treatment Market Overview: GLP-1 Agonists and
Description
The Gallup Poll found that overall, use of semaglutide medicines or liraglutides doubled from nearly 6% in the first quarter of 2024 to over 12% in Q2 + Q3 in 2025

| Health
Participants 43365 adults (18 years) with type 2 diabetes who used a GLP-1 receptor agonist or SGLT-2 inhibitor within 30 days before upper gastrointestinal endoscopy

For more expert insight and the latest market action, clickhereto watch this full episode of Yahoo Finance Live